Applying lessons from vaccination hesitancy to address birth dose Vitamin K refusal: Where has the trust gone?

Late-onset vitamin K deficiency presenting as haemorrhagic shock and severe multi-system organ failure

Vitamin K is an essential dietary cofactor required for the synthesis of active forms of vitamin K-dependent procoagulant proteins. Vitamin K deficiency, particularly late-onset deficiency occurring between 1 week and 6 months of age, can cause a life-threatening bleeding disorder. An exclusively breastfed, full-term, 6-week-old infant male presented with severe haemorrhagic shock and multi-system organ failure related to caregiver refusal of intramuscular vitamin K after birth. Coagulation studies were normalised within 8 hours of intramuscular vitamin K administration. An increasing number of caregivers are refusing intramuscular vitamin K which has led to a rise in the incidence of vitamin K deficiency bleeding. Health policy organisations around the world emphasise the benefits of intramuscular vitamin K and risks of refusal, particularly in exclusively breastfed infants who are at higher risk due to low vitamin K levels in breast milk. This case highlights the multi-system severity of this life-threatening yet preventable disorder.

Neonatologists and vitamin K hesitancy

Hemorrhagic disease of the newborn, more aptly termed "Vitamin K Deficiency Bleeding (VKDB)," has long been recognized as a cause of significant morbidity and mortality in early infancy. A single intramuscular dose of vitamin K administered at birth has virtually eliminated VKDB, and this prophylactic regimen has been recommended by the American Academy of Pediatrics since 1961. Although most newborns in the United States receive vitamin K at birth, a growing number of parents are hesitant about this intervention, citing concerns about harm from the injection, preservatives contained in the medication, and clashes with personal belief systems. Ultimately, there is distrust in the medical establishment as many of these parents also opt out of newborn ophthalmic prophylaxis and importantly, childhood vaccinations, establishing a dangerous public health precedent that will lead to resurgence of vaccine-preventable diseases. Various shared decision making models and educational efforts can assist newborn health care professionals in addressing these parental concerns so that VKDB can be effectively prevented in all newborns.

Take the Shot: A Review of Vitamin K Deficiency

Vitamin K is essential for the process of coagulation. In its absence, severe and sometimes fatal bleeding events can occur, especially in newborns. Vitamin K prophylaxis at birth has been shown to prevent morbidity and mortality associated with vitamin K deficiency bleeding (VKDB) and is recommended by multiple organizations including the American Academy of Pediatrics and the World Health Organization. Pediatricians should feel comfortable explaining the risks and benefits of vitamin K prophylaxis to families and should be equipped to recognize signs of VKDB, especially given increasing rates of parental refusal. This article aims to improve understanding of VKDB, including prevention, early recognition, and treatment. [Pediatr Ann. 2023;52(2):e42-e45.].

Hemorrhagic Disease of the Newborn: A Case Series Illustrating Preventable Harm

Newborns are susceptible to postnatal Vitamin K deficiencies from limited placental transfer, gastrointestinal absorption, and bioavailability in breast milk and formula preparations. For over 50 years, the American Academy of Pediatrics has recommended prophylactic vitamin K to prevent hemorrhagic disease in newborns. Yet, public skepticism contributes to increasing refusal rates. We present three cases of vitamin K-dependent bleeding following parental refusal of postnatal prophylaxis. Two patients experienced intracranial hemorrhage with resultant neurological devastation and mortality, respectively. The third child presented with symptomatic hematuria. Perinatal providers must partner with families and advocate vitamin K prophylaxis to limit unnecessary morbidity and mortality.

Factors associated with pediatric vaccine hesitancy of parents: a cross-sectional study in Turkey

Aim: This study aims to determine the prevalence and associated factors of vaccine hesitancy in females with children aged 12 months to 6 years who receive service from the antenatal class of a tertiary hospital in Turkey.Method: The study group includes 370 parents receiving service from a tertiary hospital. The data collection tools of the study were a descriptive data form and the Parent Attitudes about Childhood Vaccines survey.The data were analyzed using chi-square analysis and logistic regression analysis.Results: In our study, the prevalence of vaccine hesitancy was determined as 13.8% and vaccine refusal prevalence as 4.8%. In univariate analysis, vaccine hesitancy was found to be significantly higher in mothers with a university education, who got pregnant with treatment, who were not trained about pediatric vaccines in the antenatal follow-up, who followed anti-vaccine groups on social media, and who did not use vitamin D and iron supplements regularly or never used for their child. Vaccine hesitancy was significantly higher in parents who stated that their information sources of vaccines were not scientific, who were worried about vaccine ingredients (aluminum, mercury, pig gelatine) and who used alternative medicine practices (p < .05). In multivariate analysis, the risk of vaccine hesitancy increases 3.05 times in pregnancies with treatment, 3.74 times in those who did not use vitamin D or iron preparations, 3.01 times in those who followed anti-vaccine groups on social media,2.93 times in parents who were worried about the vaccine ingredients.Conclusion: Our findings suggest that the prevalence of vaccine hesitancy and risk factors should be monitored closely in the following years.